Augusta, Maine – In case you missed it, Susan Collins violated the disclosure provisions of the STOCK Act – a law she helped write – by failing to properly disclose her husband’s purchase of Pfizer corporate bond worth up to $50,000.
Read more:
NOTUS: Susan Collins Violated a Federal Transparency Law She Helped Write
By Dave Levinthal
March 26, 2026
- Sen. Susan Collins violated the disclosure provisions of a federal financial transparency law she helped write by failing to properly disclose her husband’s purchase of a pharmaceutical company corporate bond, a NOTUS review of congressional financial disclosures indicates.
- Collins’ husband, Thomas Daffron, purchased a Pfizer corporate bond worth from $15,001 to $50,000 on February 3, but Collins didn’t disclose the purchase to the Senate until Wednesday.
- In an email to NOTUS, Collins’ office acknowledged the late disclosure, which is a violation of the Stop Trading on Congressional Knowledge Act, a law passed in 2012 that Collins championed.
- Collins is also a member of the Subcommittee on Primary Health and Retirement Security, which has jurisdiction over various health-related matters, including mental health, health care disparities and the Health Resources and Services Act.
- Pfizer routinely spends more than $10 million annually on federal-level lobbying efforts, according to federal data compiled by nonpartisan research organization OpenSecrets.
###